Literature DB >> 25424816

Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries.

Sreelakshmi Sreedhar1, Anil Antony, Neethu Poulose.   

Abstract

Penta-valent-vaccine is a combination vaccine administered in a 3-dose schedule, offers protection against diphtheria, tetanus, pertussis (DPT), hepatitis B, and Haemophilus influenza type B (Hib). The vaccine is widely recommended by WHO and GAVI as a substitute for prevailing vaccination practices against the above mentioned diseases and viruses. The vaccine has met with both positive and negative responses, which leads to uncertainties about the vaccine's safety. The pros and cons of the vaccine are to be evaluated carefully before the same is added to routine immunization schedule.

Entities:  

Keywords:  DPT; Haemophilus influenza vaccine; combinational vaccine; hepatitis B vaccine; immunogenicity; pentavalent vaccine

Mesh：

Substances：

Year:  2014        PMID： 25424816      PMCID： PMC4186033          DOI： 10.4161/hv.28785

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  13 in total

1.  AEFI and the pentavalent vaccine: looking for a composite picture.

Authors:  Jacob Puliyel
Journal:  Indian J Med Ethics       Date:  2013 Jul-Sep

2.  Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India.

Authors:  V L Nag; A Ayyagari; V Venkatesh; M Ghar; V Yadav; K N Prasad
Journal:  Indian J Chest Dis Allied Sci       Date:  2001 Jan-Mar

3.  Combination vaccines for childhood immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)

Authors: 
Journal:  Am Fam Physician       Date:  1999-05-01       Impact factor: 3.292

4.  Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.

Authors:  Hitt J Sharma; Sangita Yadav; Sanjay K Lalwani; Subhash V Kapre; Suresh S Jadhav; Anita Chakravarty; Sameer S Parekh; Sonali Palkar; Subodh H Bhardwaj; Gajanan S Namjoshi; Vikas Verma
Journal:  Hum Vaccin       Date:  2011-04-01

Review 5.  Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.

Authors:  P Van Damme; M Kane; A Meheus
Journal:  BMJ       Date:  1997-04-05

6.  Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.

Authors:  J Eskola; H Käyhty; L K Gordon; T Hovi; M Stenvik; P R Rönnberg; E Kela; H Peltola
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

7.  Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. IBIS (Invasive Bacterial Infections Surveillance) Group.

Authors:  M C Steinhoff
Journal:  Pediatr Infect Dis J       Date:  1998-09       Impact factor: 2.129

8.  The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.

Authors:  C Ferreccio; J Clemens; A Avendano; I Horwitz; C Flores; L Avila; M Cayazzo; B Fritzell; M Cadoz; M Levine
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

9.  Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.

Authors:  Fernando A Guerra; Mark M Blatter; David P Greenberg; Michael Pichichero; Fernando R Noriega
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.

Authors:  T Nakayama; C Aizawa; H Kuno-Sakai
Journal:  J Allergy Clin Immunol       Date:  1999-02       Impact factor: 10.793
View more
  2 in total

Review 1.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

2.  The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2-6 Months Infants in Iran: A National Study.

Authors:  Zaher Khazaei; Ghobad Moradi; Seyed Mohsen Zahraei; Mohammad Mehdi Gouya; Elham Goodarzi; Fateme Yaghini; Daem Roshani
Journal:  Ann Glob Health       Date:  2020-02-03       Impact factor: 2.462
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.